Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Omfiloctocog alfa - Sinocelltech

Next Previous
X
Search
Drug Profile

Omfiloctocog alfa - Sinocelltech

Alternative Names: Ancain; B-domain-deleted recombinant factor-VIII - Sinocelltech; BDDr factor-VIII - Sinocelltech; BDDr FVIII - Sinocelltech; Recombinant human coagulation factor-VIII - Sinocelltech; Recombinant-B-domain-deleted factor-VIII - Sinocelltech; SCT-800

Latest Information Update: 10 Aug 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sinocelltech
  • Class Blood coagulation factors; Coagulants; Recombinant proteins
  • Mechanism of Action Blood coagulation factor replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Haemophilia A

Most Recent Events

  • 23 Jul 2021 Registered for Haemophilia A (In adolescents, In children, In the elderly, Prevention, Treatment-experienced, In adults) in China (IV)
  • 22 Feb 2021 Phase-III clinical trials in Haemophilia A (Prevention, In neonates, In infants, In children, Treatment-experienced) in China (IV) prior to February 2021 (Sinocelltech pipeline, February 2021)
  • 17 May 2019 Sinocelltech plans a phase III trial for Haemophilia A (In neonates, In infants, In children, Second-line therapy or greater) in December 2019 (NCT03947320)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top